Gene · 3913
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monitoring of single extracellular vesicle heterogeneity in cancer progression and therapy. | Front Oncol | 2023 | 37823055 | PubTator, text mining | PubMed |
| Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature. | Brain Behav Immun Health | 2023 | 37822873 | PubTator, text mining | PubMed |
| Advances in the design, generation, and application of tissue-engineered myocardial equivalents. | Front Bioeng Biotechnol | 2023 | 37811368 | PubTator, text mining | PubMed |
| Comprehensive analysis of basement membrane and immune checkpoint related lncRNA and its prognostic value in hepatocellular carcinoma via machine learning. | Heliyon | 2023 | 37810862 | PubTator, text mining | PubMed |
| The role of peroxidasin in solid cancer progression. | Biochem Soc Trans | 2023 | 37801286 | PubTator, text mining | PubMed |
| Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. | Clin Transl Med | 2023 | 37784253 | PubTator, text mining | PubMed |
| Potential molecular targets and drugs for basement membranes-related intervertebral disk degeneration through bioinformatics analysis and molecular docking. | BMC Musculoskelet Disord | 2023 | 37784117 | PubTator, text mining | PubMed |
| Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma. | Front Cell Dev Biol | 2023 | 37779898 | PubTator, text mining | PubMed |
| Cystic fibrosis autoantibody signatures associate with Staphylococcus aureus lung infection or cystic fibrosis-related diabetes. | Front Immunol | 2023 | 37767091 | PubTator, text mining | PubMed |
| Crosstalk between integrin/FAK and Crk/Vps25 governs invasion of bovine mammary epithelial cells by S. agalactiae. | iScience | 2023 | 37766995 | PubTator, text mining | PubMed |
| ADAM11 a novel regulator of Wnt and BMP4 signaling in neural crest and cancer. | Front Cell Dev Biol | 2023 | 37766964 | PubTator, text mining | PubMed |
| Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care. | Pharmaceutics | 2023 | 37765300 | PubTator, text mining | PubMed |
| Steroid-Resistant Nephrotic Syndrome Caused by NUP93 Pathogenic Variants. | J Clin Med | 2023 | 37762751 | PubTator, text mining | PubMed |
| The Mechanotransduction Signaling Pathways in the Regulation of Osteogenesis. | Int J Mol Sci | 2023 | 37762629 | PubTator, text mining | PubMed |
| Matricellular Proteins in the Homeostasis, Regeneration, and Aging of Skin. | Int J Mol Sci | 2023 | 37762584 | PubTator, text mining | PubMed |
| Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier. | Int J Mol Sci | 2023 | 37762420 | PubTator, text mining | PubMed |
| Skin Cancer Microenvironment: What We Can Learn from Skin Aging? | Int J Mol Sci | 2023 | 37762344 | PubTator, text mining | PubMed |
| A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome. | Biomedicines | 2023 | 37761001 | PubTator, text mining | PubMed |
| Usefulness of COL11A1 as a Prognostic Marker of Tumor Infiltration. | Biomedicines | 2023 | 37760937 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases and the Pathogenesis of Recurrent Corneal Erosions and Epithelial Basement Membrane Dystrophy. | Biology (Basel) | 2023 | 37759662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/papers?page=15